Maxwell  Krakowiak net worth and biography

Maxwell Krakowiak Biography and Net Worth

Insider of Revvity

Max Krakowiak is SVP and Chief Financial Officer at Revvity, responsible for leading the Company’s global finance organization.

Max is a team player who fosters a strong culture centered on camaraderie, talent development and winning the controllables. He has played an integral role on Revvity’s finance leadership team since 2018. Before being appointed to his current role in August 2022, Max served as VP of Corporate Finance overseeing financial planning and analysis as well as the commercial and business development finance organizations. He has also served as the Company’s chief of staff for finance and focused on driving global finance transformation through people, process and automation.

Prior to joining the Company, Max spent seven years at GE where he most recently served as a member of the executive leadership team in the company’s corporate audit staff. He worked across GE’s global operating segments to oversee teams responsible for corporate strategy, external investigations and investor relations. Max is also a graduate of the GE Financial Management leadership program.

Max holds a bachelor’s degree in finance from Fordham University in New York City. He also spent time as a minor league baseball player in the Seattle Mariners organization.

What is Maxwell Krakowiak's net worth?

The estimated net worth of Maxwell Krakowiak is at least $0.00 as of March 29th, 2023. Mr. Krakowiak owns 7,202 shares of Revvity stock worth more than $0 as of April 26th. This net worth estimate does not reflect any other assets that Mr. Krakowiak may own. Learn More about Maxwell Krakowiak's net worth.

How do I contact Maxwell Krakowiak?

The corporate mailing address for Mr. Krakowiak and other Revvity executives is 940 WINTER STREET, WALTHAM MA, 02451. Revvity can also be reached via phone at (781) 663-6900 and via email at [email protected]. Learn More on Maxwell Krakowiak's contact information.

Has Maxwell Krakowiak been buying or selling shares of Revvity?

Maxwell Krakowiak has not been actively trading shares of Revvity in the last ninety days. Most recently, Maxwell Krakowiak sold 322 shares of the business's stock in a transaction on Wednesday, March 29th. The shares were sold at an average price of $130.00, for a transaction totalling $41,860.00. Following the completion of the sale, the insider now directly owns 7,202 shares of the company's stock, valued at $936,260. Learn More on Maxwell Krakowiak's trading history.

Who are Revvity's active insiders?

Revvity's insider roster includes Peter Barrett (Director), Joel Goldberg (Insider), Sylvie Gregoire (Director), Maxwell Krakowiak (Insider), James Mock (Insider), Andrew Okun (Insider), Prahlad Singh (Insider), Daniel Tereau (Insider), and Tajinder Vohra (Insider). Learn More on Revvity's active insiders.

Maxwell Krakowiak Insider Trading History at Revvity

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/29/2023Sell322$130.00$41,860.007,202View SEC Filing Icon  
See Full Table

Maxwell Krakowiak Buying and Selling Activity at Revvity

This chart shows Maxwell Krakowiak's buying and selling at Revvity by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Revvity Company Overview

Revvity logo
Revvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $127.73
Low: $115.24
High: $137.11

2 Week Range

Now: N/A

Volume

1,633,000 shs

Average Volume

851,117 shs

Market Capitalization

$14.57 billion

P/E Ratio

15.01

Dividend Yield

0.24%

Beta

1.1